Bausch & Lomb Corp

Bausch + Lomb Corporation develops, manufactures, and markets eye health products worldwide across three operating segments: Vision Care, Pharmaceuticals, and Surgical. Its Vision Care unit provides contact lenses, including daily disposables and specialty lenses, as well as consumer eye care items such as lens care solutions, over-the-counter eye drops, and nutritional supplements. The Pharmaceuticals division offers prescription and generic medications for ocular conditions, including dry eye disease, glaucoma, ocular hypertension, and post-operative inflammation. The Surgical segment supplies ophthalmic surgical devices, diagnostic and procedural equipment, intraocular lenses, delivery systems, and surgical instruments. The company provides its products to patients, consumers, eye care professionals, optometrists, physicians, and retail partners.

The company operates globally with approximately 13,000 employees and maintains a business presence across approximately 100 countries. Its research and development network comprises 13 facilities with around 900 dedicated personnel working on clinical programs worldwide. The provided text does not identify the location of its corporate headquarters.

Summary of the business section of Bausch & Lomb's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had approximately 13,000 employees, which included approximately 7,000 in production, 4,200 in sales and marketing, 900 in general and administrative positions and 900 in R&D.”